Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Basiliximab not worth it in renal transplantation

    • 7 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Basiliximab not worth it in renal transplantation. Pharmacoecon. Outcomes News 408, 7 (2003). https://doi.org/10.1007/BF03276120

    Download citation

    Keywords

    • Renal Transplant
    • Acute Rejection
    • Renal Transplant Recipient
    • Basiliximab
    • Drug Acquisition Cost